PAVmed (PAVM) Enterprise Value (2022 - 2025)
Historic Enterprise Value for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$41.9 million.
- PAVmed's Enterprise Value changed N/A to -$41.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.9 million, marking a year-over-year change of. This contributed to the annual value of -$30.5 million for FY2024, which is 39952.82% down from last year.
- Latest data reveals that PAVmed reported Enterprise Value of -$41.9 million as of Q3 2025.
- In the past 5 years, PAVmed's Enterprise Value ranged from a high of $29.8 million in Q2 2024 and a low of -$53.0 million during Q1 2025
- For the 4-year period, PAVmed's Enterprise Value averaged around -$19.6 million, with its median value being -$19.1 million (2022).
- Data for PAVmed's Enterprise Value shows a peak YoY increase of 55986.73% (in 2024) and a maximum YoY decrease of 39952.82% (in 2024) over the last 5 years.
- Over the past 4 years, PAVmed's Enterprise Value (Quarter) stood at -$19.1 million in 2022, then skyrocketed by 153.19% to $10.2 million in 2023, then crashed by 399.53% to -$30.5 million in 2024, then plummeted by 37.52% to -$41.9 million in 2025.
- Its Enterprise Value was -$41.9 million in Q3 2025, compared to -$45.7 million in Q2 2025 and -$53.0 million in Q1 2025.